{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:33:50Z","timestamp":1740123230612,"version":"3.37.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11033-019-04649-2","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T05:56:03Z","timestamp":1548914163000},"page":"2003-2011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature"],"prefix":"10.1007","volume":"46","author":[{"given":"Nada","family":"Assaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"El-Cheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Farra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaher","family":"Chakhachiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Nassif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazi","family":"Zaatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-8191","authenticated-orcid":false,"given":"Rami","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"issue":"3","key":"4649_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3390\/jcm4030460","volume":"4","author":"S Yohe","year":"2015","unstructured":"Yohe S (2015) Molecular genetic markers in acute myeloid leukemia. J Clin Med 4(3):460\u2013478","journal-title":"J Clin Med"},{"unstructured":"Swerdlow SH, Harris CE, Jaffe NL, Pileri ES, Stein SA, Thiele HJ (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn, vol 2","key":"4649_CR2"},{"issue":"20","key":"4649_CR3","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"4","key":"4649_CR4","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H et al (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447","journal-title":"Blood"},{"issue":"6","key":"4649_CR5","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M (2017) Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J 7(6):e577","journal-title":"Blood Cancer J"},{"issue":"23","key":"4649_CR6","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1200\/JCO.2017.72.6745","volume":"35","author":"JP Leonard","year":"2017","unstructured":"Leonard JP, Martin P, Roboz GJ (2017) Practical implications of the 2016 revision of the World Health Organization classification of lymphoid and myeloid neoplasms and acute leukemia. J Clin Oncol 35(23):2708\u20132715","journal-title":"J Clin Oncol"},{"key":"4649_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.14694\/EDBK_175437","volume":"37","author":"ES Jaffe","year":"2017","unstructured":"Jaffe ES, Barr PM, Smith SM (2017) Understanding the new WHO classification of lymphoid malignancies: why it\u2019s important and how it will affect practice. Am Soc Clin Oncol Educ Book 37:535\u2013546","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"4649_CR8","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.clml.2015.02.011","volume":"15 Suppl","author":"L Halabi El","year":"2015","unstructured":"El Halabi L et al (2015) Assessment of molecular markers in AML patients: a hospital-based study in Lebanon. Clin Lymphoma Myeloma Leuk 15 Suppl:S80\u2013S84","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"11","key":"4649_CR9","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/bjc.2011.450","volume":"105","author":"A Smith","year":"2011","unstructured":"Smith A et al (2011) Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer 105(11):1684\u20131692","journal-title":"Br J Cancer"},{"issue":"17","key":"4649_CR10","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","volume":"119","author":"G Juliusson","year":"2012","unstructured":"Juliusson G et al (2012) Acute myeloid leukemia in the real world: why population-based registries are needed. Blood 119(17):3890\u20133899","journal-title":"Blood"},{"issue":"9","key":"4649_CR11","first-page":"2459","volume":"18","author":"Z Abuhelwa","year":"2017","unstructured":"Abuhelwa Z et al (2017) Characteristics of de novo acute myeloid leukemia patients in Palestine: experience of An-Najah National University Hospital. Asian Pac J Cancer Prev 18(9):2459\u20132464","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"4649_CR12","first-page":"457","volume":"64","author":"N Braham-Jmili","year":"2006","unstructured":"Braham-Jmili N et al (2006) Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia. Ann Biol Clin 64(5):457\u2013465","journal-title":"Ann Biol Clin"},{"issue":"10","key":"4649_CR13","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/leu.2009.107","volume":"23","author":"Y Cheng","year":"2009","unstructured":"Cheng Y et al (2009) Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China. Leukemia 23(10):1801\u20131806","journal-title":"Leukemia"},{"issue":"3","key":"4649_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1385\/MO:19:3:141","volume":"19","author":"M Bhutani","year":"2002","unstructured":"Bhutani M et al (2002) Lympho-hemopoietic malignancies in India. Med Oncol 19(3):141\u2013150","journal-title":"Med Oncol"},{"key":"4649_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/1471-2407-14-438","volume":"14","author":"MS Hossain","year":"2014","unstructured":"Hossain MS et al (2014) Diagnosed hematological malignancies in Bangladesh\u2014a retrospective analysis of over 5000 cases from 10 specialized hospitals. BMC Cancer 14:438","journal-title":"BMC Cancer"},{"key":"4649_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12885-016-2205-5","volume":"16","author":"M Elidrissi Errahhali","year":"2016","unstructured":"Elidrissi Errahhali M et al (2016) Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years. BMC Cancer 16:159","journal-title":"BMC Cancer"},{"issue":"1","key":"4649_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1179\/102453312X13221316477417","volume":"17","author":"A Gmidene","year":"2012","unstructured":"Gmidene A et al (2012) Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia. Hematology 17(1):9\u201314","journal-title":"Hematology"},{"issue":"5","key":"4649_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.thj.6200544","volume":"5","author":"AK Enjeti","year":"2004","unstructured":"Enjeti AK, Tien SL, Sivaswaren CR (2004) Cytogenetic abnormalities in de novo acute myeloid leukemia in adults: relation to morphology, age, sex and ethnicity\u2014a single center study from Singapore. Hematol J 5(5):419\u2013425","journal-title":"Hematol J"},{"issue":"2","key":"4649_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1046\/j.1365-2141.2003.04568.x","volume":"123","author":"BS Preiss","year":"2003","unstructured":"Preiss BS et al (2003) Cytogenetic findings in adult de novo acute myeloid leukaemia. A population-based study of 303\/337 patients. Br J Haematol 123(2):219\u2013234","journal-title":"Br J Haematol"},{"issue":"5","key":"4649_CR20","first-page":"398","volume":"36","author":"W Cai","year":"2015","unstructured":"Cai W et al (2015) Clinical and laboratory characteristics of 12 Ph\/BCR-ABL positive acute myeloid leukemia patients. Zhonghua Xue Ye Xue Za Zhi 36(5):398\u2013402","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"6","key":"4649_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.leukres.2003.10.027","volume":"28","author":"YK Keung","year":"2004","unstructured":"Keung YK et al (2004) Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature. Leuk Res 28(6):579\u2013586","journal-title":"Leuk Res"},{"issue":"4","key":"4649_CR22","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1309\/B4NVER1AJJ84CTUU","volume":"127","author":"CP Soupir","year":"2007","unstructured":"Soupir CP et al (2007) Philadelphia chromosome-positive acute myeloid leukemia: a rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 127(4):642\u2013650","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"4649_CR23","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.leukres.2011.04.011","volume":"35","author":"M Atfy","year":"2011","unstructured":"Atfy M, Al NM, Azizi, Elnaggar AM (2011) Incidence of Philadelphia-chromosome in acute myelogenous leukemia and biphenotypic acute leukemia patients: and its role in their outcome. Leuk Res 35(10):1339\u20131344","journal-title":"Leuk Res"},{"issue":"3","key":"4649_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B et al (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352(3):254\u2013266","journal-title":"N Engl J Med"},{"issue":"22","key":"4649_CR25","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"TJ Ley","year":"2013","unstructured":"Ley TJ et al (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368(22):2059\u20132074","journal-title":"N Engl J Med"},{"issue":"10","key":"4649_CR26","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1182\/blood-2005-08-3167","volume":"107","author":"C Thiede","year":"2006","unstructured":"Thiede C et al (2006) Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 107(10):4011\u20134020","journal-title":"Blood"},{"issue":"1","key":"4649_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12288-017-0821-0","volume":"34","author":"J Bhattacharyya","year":"2018","unstructured":"Bhattacharyya J et al (2018) Prevalence and clinical significance of FLT3 and NPM1 mutations in acute myeloid leukaemia patients of Assam, India. Indian J Hematol Blood Transfus 34(1):32\u201342","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"3","key":"4649_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/IJPM.IJPM_501_15","volume":"60","author":"S Sazawal","year":"2017","unstructured":"Sazawal S et al (2017) NPM1 and FLT3 mutations in acute myeloid leukemia with normal karyotype: Indian perspective. Indian J Pathol Microbiol 60(3):355\u2013359","journal-title":"Indian J Pathol Microbiol"},{"issue":"11","key":"4649_CR29","first-page":"1813","volume":"60","author":"MA Sofan","year":"2014","unstructured":"Sofan MA et al (2014) NPM1 gene mutation in Egyptian patients with cytogenetically normal acute myeloid leukemia. Clin Lab 60(11):1813\u20131822","journal-title":"Clin Lab"},{"issue":"1","key":"4649_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4274\/Tjh.2013.0023","volume":"31","author":"G Balatzenko","year":"2014","unstructured":"Balatzenko G et al (2014) NPM1 gene type A mutation in bulgarian adults with acute myeloid leukemia: a single-institution study. Turk J Haematol 31(1):40\u201348","journal-title":"Turk J Haematol"},{"issue":"8","key":"4649_CR31","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2005-04-1733","volume":"106","author":"T Suzuki","year":"2005","unstructured":"Suzuki T et al (2005) Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood 106(8):2854\u20132861","journal-title":"Blood"},{"issue":"6","key":"4649_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/ijlh.12204","volume":"36","author":"RC Marshall","year":"2014","unstructured":"Marshall RC et al (2014) Lower frequency of NPM1 and FLT3-ITD mutations in a South African adult de novo AML cohort. Int J Lab Hematol 36(6):656\u2013664","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"4649_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.arcmed.2016.06.003","volume":"47","author":"J Cuervo-Sierra","year":"2016","unstructured":"Cuervo-Sierra J et al (2016) Prevalence and clinical significance of FLT3 mutation status in acute myeloid leukemia patients: a multicenter study. Arch Med Res 47(3):172\u2013179","journal-title":"Arch Med Res"},{"issue":"1","key":"4649_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood.V100.1.59","volume":"100","author":"S Schnittger","year":"2002","unstructured":"Schnittger S et al (2002) Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100(1):59\u201366","journal-title":"Blood"},{"unstructured":"Swerdlow SH, ed (2008) World Health Organization classification of tumours, Lyon, 4th edn","key":"4649_CR35"},{"issue":"12","key":"4649_CR36","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","volume":"99","author":"C Thiede","year":"2002","unstructured":"Thiede C et al (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99(12):4326\u20134335","journal-title":"Blood"},{"issue":"6","key":"4649_CR37","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"PD Kottaridis","year":"2001","unstructured":"Kottaridis PD et al (2001) The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials. Blood 98(6):1752\u20131759.","journal-title":"Blood"},{"issue":"1","key":"4649_CR38","first-page":"21","volume":"13","author":"F Zaker","year":"2010","unstructured":"Zaker F, Mohammadzadeh M, Mohammadi M (2010) Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes. Arch Iran Med 13(1):21\u201325","journal-title":"Arch Iran Med"},{"issue":"20","key":"4649_CR39","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1182\/blood-2011-03-343988","volume":"118","author":"Y Shen","year":"2011","unstructured":"Shen Y et al (2011) Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood 118(20):5593\u20135603","journal-title":"Blood"},{"issue":"6","key":"4649_CR40","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1007\/s13277-015-4601-x","volume":"37","author":"H Gou","year":"2016","unstructured":"Gou H et al (2016) The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China. Tumour Biol 37(6):7357\u20137370","journal-title":"Tumour Biol"},{"key":"4649_CR41","doi-asserted-by":"crossref","first-page":"141360","DOI":"10.1155\/2014\/141360","volume":"2014","author":"G Elyamany","year":"2014","unstructured":"Elyamany G et al (2014) Frequency and prognostic relevance of FLT3 mutations in Saudi acute myeloid leukemia patients. Adv Hematol 2014:141360","journal-title":"Adv Hematol"},{"issue":"19","key":"4649_CR42","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1182\/bloodadvances.2017009019","volume":"1","author":"P Boddu","year":"2017","unstructured":"Boddu P et al (2017) Co-occurrence of FLT3-TKD and NPM1 mutations defines a highly favorable prognostic AML group. Blood Adv 1(19):1546\u20131550","journal-title":"Blood Adv"},{"issue":"8","key":"4649_CR43","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.leu.2403838","volume":"19","author":"M Yanada","year":"2005","unstructured":"Yanada M et al (2005) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis. Leukemia 19(8):1345\u20131349","journal-title":"Leukemia"},{"issue":"16","key":"4649_CR44","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1200\/JCO.2009.26.2501","volume":"28","author":"CL Green","year":"2010","unstructured":"Green CL et al (2010) Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. J Clin Oncol 28(16):2739\u20132747","journal-title":"J Clin Oncol"},{"issue":"3","key":"4649_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/85820","volume":"27","author":"T Pabst","year":"2001","unstructured":"Pabst T et al (2001) Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha), in acute myeloid leukemia. Nat Genet 27(3):263\u2013270","journal-title":"Nat Genet"},{"issue":"31","key":"4649_CR46","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1200\/JCO.2008.17.5554","volume":"26","author":"G Marcucci","year":"2008","unstructured":"Marcucci G et al (2008) Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 26(31):5078\u20135087","journal-title":"J Clin Oncol"},{"issue":"13","key":"4649_CR47","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2008-09-179895","volume":"113","author":"BJ Wouters","year":"2009","unstructured":"Wouters BJ et al (2009) Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood 113(13):3088\u20133091","journal-title":"Blood"},{"issue":"4","key":"4649_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12288-015-0623-1","volume":"32","author":"SB Said","year":"2016","unstructured":"Said SB et al (2016) Prevalence and prognostic impact of CEBPA gene mutation (simplified assay technique) in Egyptian acute myeloid leukemia patients with normal cytogenetics. Indian J Hematol Blood Transfus 32(4):405\u2013411","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"4649_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1179\/1607845412Y.0000000032","volume":"18","author":"MM Awad","year":"2013","unstructured":"Awad MM et al (2013) CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis. Hematology 18(2):61\u201368","journal-title":"Hematology"},{"issue":"24","key":"4649_CR50","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","volume":"24","author":"P Paschka","year":"2006","unstructured":"Paschka P et al (2006) Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol 24(24):3904\u20133911","journal-title":"J Clin Oncol"},{"issue":"9","key":"4649_CR51","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/leu.2013.186","volume":"27","author":"C Allen","year":"2013","unstructured":"Allen C et al (2013) The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia. Leukemia 27(9):1891\u20131901","journal-title":"Leukemia"},{"key":"4649_CR52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.leukres.2018.01.008","volume":"66","author":"Y Harada","year":"2018","unstructured":"Harada Y et al (2018) Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study. Leuk Res 66:20\u201327","journal-title":"Leuk Res"},{"issue":"36","key":"4649_CR53","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1200\/JCO.2012.43.4738","volume":"30","author":"K Mr\u00f3zek","year":"2012","unstructured":"Mr\u00f3zek K et al (2012) Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol 30(36):4515\u20134523","journal-title":"J Clin Oncol"},{"issue":"2","key":"4649_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ejh.12815","volume":"98","author":"PG Hemmati","year":"2017","unstructured":"Hemmati PG et al (2017) Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukaemia undergoing allogeneic stem cell transplantation. Eur J Haematol 98(2):160\u2013168","journal-title":"Eur J Haematol"},{"issue":"9","key":"4649_CR55","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","volume":"35","author":"L Bullinger","year":"2017","unstructured":"Bullinger L, Dohner K, Dohner H (2017) Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol 35(9):934\u2013946","journal-title":"J Clin Oncol"},{"issue":"10","key":"4649_CR56","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/leu.2017.48","volume":"31","author":"M Wang","year":"2017","unstructured":"Wang M et al (2017) Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. Leukemia 31(10):2029\u20132036","journal-title":"Leukemia"},{"issue":"15","key":"4649_CR57","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1002\/cncr.29383","volume":"121","author":"E Jabbour","year":"2015","unstructured":"Jabbour E et al (2015) New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia. Cancer 121(15):2517\u20132528","journal-title":"Cancer"},{"issue":"11","key":"4649_CR58","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.mayocp.2016.09.010","volume":"91","author":"S Paul","year":"2016","unstructured":"Paul S, Kantarjian H, Jabbour EJ (2016) Adult acute lymphoblastic leukemia. Mayo Clin Proc 91(11):1645\u20131666","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"4649_CR59","doi-asserted-by":"publisher","first-page":"64","DOI":"10.31768\/2312-8852.2015.37(1):64-69","volume":"37","author":"A Lahjouji","year":"2015","unstructured":"Lahjouji A et al (2015) The immunophenotype of adult T acute lymphoblastic leukemia in Morocco. Exp Oncol 37(1):64\u201369","journal-title":"Exp Oncol"},{"issue":"7","key":"4649_CR60","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1080\/10428190902919184","volume":"50","author":"IB Hassan","year":"2009","unstructured":"Hassan IB et al (2009) Acute leukemia among the adult population of United Arab Emirates: an epidemiological study. Leuk Lymphoma 50(7):1138\u20131147","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"4649_CR61","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1658-3876(09)50021-0","volume":"2","author":"KM Charafeddine","year":"2009","unstructured":"Charafeddine KM et al (2009) Long-term outcome of adult acute lymphoblastic leukemia in Lebanon: a single institution experience from the American University of Beirut. Hematol Oncol Stem Cell Ther 2(2):333\u2013339","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"4649_CR62","doi-asserted-by":"publisher","first-page":"e2013024","DOI":"10.4084\/mjhid.2013.024","volume":"5","author":"S Abbasi","year":"2013","unstructured":"Abbasi S, Maleha F, Shobaki M (2013) Acute lymphoblastic leukemia experience: epidemiology and outcome of two different regimens. Mediterr J Hematol Infect Dis 5(1):e2013024","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"3","key":"4649_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jnci.2013.05.004","volume":"25","author":"MA Samra","year":"2013","unstructured":"Samra MA et al (2013) The prognostic significance of minimal residual disease in adult Egyptian patients with precursor acute lymphoblastic leukemia. J Egypt Natl Canc Inst 25(3):135\u2013142","journal-title":"J Egypt Natl Canc Inst"},{"issue":"7","key":"4649_CR64","doi-asserted-by":"publisher","first-page":"858","DOI":"10.6004\/jnccn.2012.0089","volume":"10","author":"JC Alvarnas","year":"2012","unstructured":"Alvarnas JC et al (2012) Acute lymphoblastic leukemia. J Natl Compr Cancer Netw 10(7):858\u2013914","journal-title":"J Natl Compr Cancer Netw"},{"issue":"2","key":"4649_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hon.840","volume":"26","author":"A Gmidene","year":"2008","unstructured":"Gmidene A et al (2008) Cytogenetic analysis of 298 newly diagnosed cases of acute lymphoblastic leukaemia in Tunisia. Hematol Oncol 26(2):91\u201397","journal-title":"Hematol Oncol"},{"issue":"2","key":"4649_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/10245330600574300","volume":"11","author":"LA Mahmoud","year":"2006","unstructured":"Mahmoud LA et al (2006) A study for evaluation of different diagnostic approaches in acute leukemia in Egypt. Hematology 11(2):87\u201395","journal-title":"Hematology"},{"key":"4649_CR67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan CG (2012) The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2012:389\u2013396","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"4649_CR68","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/bjh.14916","volume":"179","author":"O Wolach","year":"2017","unstructured":"Wolach O, Amitai I, DeAngelo DJ (2017) Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia. Br J Haematol 179(5):705\u2013723","journal-title":"Br J Haematol"},{"issue":"20","key":"4649_CR69","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X et al (2004) Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 22(20):4075\u20134086","journal-title":"J Clin Oncol"},{"issue":"11","key":"4649_CR70","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJMoa1605085","volume":"375","author":"S Maury","year":"2016","unstructured":"Maury S et al (2016) Rituximab in B-lineage adult acute lymphoblastic leukemia. N Engl J Med 375(11):1044\u20131053","journal-title":"N Engl J Med"},{"issue":"1","key":"4649_CR71","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1182\/asheducation-2016.1.573","volume":"2016","author":"N Gokbuget","year":"2016","unstructured":"Gokbuget N (2016) Treatment of older patients with acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program 2016(1):573\u2013579","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"4649_CR72","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","volume":"8","author":"YF Liu","year":"2016","unstructured":"Liu YF et al (2016) Genomic profiling of adult and pediatric B-cell acute lymphoblastic leukemia. EBioMedicine 8:173\u2013183","journal-title":"EBioMedicine"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-04649-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-04649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-04649-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T19:38:30Z","timestamp":1606333110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-04649-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["4649"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-04649-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"6 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors do not have any conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board as a retrospective chart review and data collection with waiver of informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}